Abstract
Catastrophic antiphospholipid syndrome (CAPS) is characterized by life-threatening diffuse thrombotic manifestations involving particularly small vessels of kidney, lungs, brain and skin. We report a 20-year-old female with systemic lupus erythematosus and secondary antiphospholipid syndrome who presented typical organ and histological involvement as seen in CAPS but with protracted course suggesting a “smoldering” form of the disease.
References
Santiago M, Martinelli R, Ko A et al (2001) Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. Clin Exp Rheumatol 19:425–430
Asherson RA, Cervera R, de Groot PG et al (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12:530–534. doi:10.1191/0961203303lu394oa
Asherson RA, Espinosa G, Menahem S et al (2007) Relapsing catastrophic antiphospholipid syndrome: report of three cases. Semin Arthritis Rheum 37:366–372
Borba EF, Bonfá E, Asherson RA (2005) Catastrophic antiphospholipid syndrome (Asherson’s Syndrome) revealed. Rev Bras Reumatologia 45:374–381
Zamora MR, Warner ML, Tuder R, Schwarz MI (1997) Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 76:192–202. doi:10.1097/00005792-199705000-00005
Green RJ, Ruoss SJ, Kraft SA, Duncan SR, Berry GJ, Raffin TA (1996) Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 110:1305–1316. doi:10.1378/chest.110.5.1305
Stojanovich L (2006) Pulmonary manifestations in antiphospholipid syndrome. Autoimmun Rev 5:344–348. doi:10.1016/j.autrev.2006.02.002
Deane KD, West SG (2005) Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum 35:154–165. doi:10.1016/j.semarthrit.2005.05.006
Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507–518
Uthman I, Khamashta M (2006) Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum 35:360–367. doi:10.1016/j.semarthrit.2006.01.001
Daugas E, Nochy D, Huong DL et al (2002) Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13:42–52. doi:10.1159/000049149
Khamashta MA, Ruiz-Irastorza G (2006) Management of thrombosis in antiphospholipid syndrome. In: Khamashta MA (ed) Hughes syndrome: antiphospholipid syndrome, 2nd edn. Springer, NY, pp 547–554
Acknowledgments
M. S. is currently receiving a scholarship from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Athanazio, D., Rocha, M.C., de Souza e Souza, T.G. et al. Chronic catastrophic-like antiphospholipid syndrome: a “smoldering” variant?. Rheumatol Int 30, 123–125 (2009). https://doi.org/10.1007/s00296-009-0913-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-0913-8